Y-mAbs to Participate at Citis 2024 Global Healthcare Conference
YMAB Stock | USD 10.01 0.27 2.63% |
About 61% of Y MAbs' investor base is looking to short. The analysis of the overall investor sentiment regarding Y mAbs Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Y MAbs' historical and current headlines, can help investors time the market. In addition, many technical investors use Y mAbs Therapeutics stock news signals to limit their universe of possible portfolio assets.
YMAB |
NEW YORK, Nov. 27, 2024 -- Y-mAbs Therapeutics, Inc. , a commercial-stage biopharmaceutical compan
Read at gurufocus.com
Y MAbs Fundamental Analysis
We analyze Y MAbs' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Y MAbs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Y MAbs based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
Y MAbs is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Y mAbs Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Y MAbs stock to make a market-neutral strategy. Peer analysis of Y MAbs could also be used in its relative valuation, which is a method of valuing Y MAbs by comparing valuation metrics with similar companies.
Peers
Y MAbs Related Equities
CCCC | C4 Therapeutics | 9.28 | ||||
STRO | Sutro Biopharma | 4.26 | ||||
BDTX | Black Diamond | 2.09 | ||||
MIRM | Mirum Pharmaceuticals | 1.82 | ||||
EWTX | Edgewise Therapeutics | 1.15 | ||||
GBIO | Generation Bio | 0.79 | ||||
PCVX | Vaxcyte | 0.69 | ||||
MRUS | Merus BV | 0.58 | ||||
TVTX | Travere Therapeutics | 0.37 | ||||
DAWN | Day One | 0.45 | ||||
ERAS | Erasca | 0.67 | ||||
RVMD | Revolution Medicines | 1.82 | ||||
MRSN | Mersana Therapeutics | 2.75 | ||||
LRMR | Larimar Therapeutics | 2.81 | ||||
KRON | Kronos Bio | 2.86 | ||||
ARQT | Arcutis Biotherapeutics | 2.89 | ||||
ZNTL | Zentalis Pharmaceuticals | 3.05 | ||||
PASG | Passage Bio | 3.80 | ||||
SNDX | Syndax Pharmaceuticals | 3.98 | ||||
BLUE | Bluebird Bio | 7.14 |
Complementary Tools for YMAB Stock analysis
When running Y MAbs' price analysis, check to measure Y MAbs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Y MAbs is operating at the current time. Most of Y MAbs' value examination focuses on studying past and present price action to predict the probability of Y MAbs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Y MAbs' price. Additionally, you may evaluate how the addition of Y MAbs to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
CEOs Directory Screen CEOs from public companies around the world |